BioAdvance News

Niiki Pharma Reports on Synergistic Activity of Novel Anti-Cancer Agent NKP-1339 with Other Anti-Cancer Agents

By WebmasterNovember 15, 2011November 1st, 2024No Comments

Niiki Pharma Reports on Synergistic Activity of Novel Anti-Cancer Agent NKP-1339 with Other Anti-Cancer Agents
Read more here

Previous PostGalleon Pharmaceuticals Names Lynne Brookes Senior Vice President and Chief Business Officer
Next PostBioAdvance Names Sam Katz as Chair and Elects J. Larry Jameson, M.D., Ph.D., and Lauren Lenfest as Directors